Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance

Journal of Clinical Lipidology

Volumn 5, Issue 4, 2011, Pages 308-315

  Kennedy, Steven P ^a   Barnas, Gary P ^a   Schmidt, Michael J ^a   Glisczinski, Marcy S ^a   Paniagua, Angela C ^a  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Clinical trials as topic; Hydroxymethylglutaryl coenzyme A reductase inhibitors; Random allocation; Rosuvastatin calcium; Therapeutic uses

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN; MEVINOLIN; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEMALE; GOVERNMENT; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; MALE; MYALGIA; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG TOLERANCE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MUSCULAR DISEASES; PYRIMIDINES; SULFONAMIDES; TREATMENT OUTCOME;

EID: 79960831385     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.03.454     Document Type: Article

References (14)

1. Anonymous Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
2. J. Sheperd, S.M. Cobbe, I. Ford, C.G. Isles, A.R. Lorimer, and P.W. Macfarlane Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 333 1995 1301 1307
3. Anonymous Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group N Engl J Med 339 1998 1349 1357
4. J.R. Downs, M. Clearfield, S. Weis, E. Whitney, D.R. Shapiro, and P.A. Beere Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels JAMA 279 1998 1615 1622 (Pubitemid 28248586)
5. National Cholesterol Education Program Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report [see comment] Circulation 106 2002 3143 3421
6. E. Bruckert, G. Hayem, S. Dejager, C. Yau, and B. Begaud Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - the PRIMO study Cardiovasc Drugs Ther 19 2005 403 414 (Pubitemid 43228152)
7. J.M. Backes, P.M. Moriarty, J.F. Ruisinger, and C.A. Gibson Effects of once weekly rosuvastatin among patients with a prior statin intolerance Am J Cardiol 100 2007 554 555
8. J.F. Ruisinger, J.M. Backes, C.A. Gibson, and P.M. Moriarty Once-a-week rosuvastatin (2.5 to 20 mg) in patients with a previous statin intolerance Am J Cardiol 103 2009 393 394
9. M. Gardala, A.K. Kearns, and P.D. Thompson Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins Am J Cardiol 101 2008 1747 1748
10. J.M. Backes, C.V. Venero, C.A. Gibson, J.F. Ruisinger, P.A. Howard, and P.D. Thompson Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance Ann Pharmacother 42 2008 341 346 (Pubitemid 351429598)
11. B.D. Mackie, S. Satija, C. Nell, J. Miller, and L.S. Sperling Monday, wednesday, and friday dosing of rosuvastatin in patients previously intolerant to statin therapy Am J Cardiol 99 2007 291 (Pubitemid 46072773)
12. M.S. Matalka, M.C. Ravnan, and P.C. Deedwania Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS) Am Heart J 144 2002 674 677
13. J.C. Ferrer-García, J. Pérez-Silvestre, I. Martínez-Mir, and A. Herrera-Ballester Alternate-day dosing of atorvastatin: effects in treating type 2 diabetic patients with dyslipidaemia Acta Diabetol 43 2006 75 78 (Pubitemid 44875441)
14. S. Wongwiwatthananukit, N. Sansanayudh, R. Dhummauppakorn, and C. Kitiyadisai Efficacy and safety of rosuvastatin every other day compared with once daily in patients with hypercholesterolemia Ann Pharmacother 40 2006 1917 1923 (Pubitemid 44747459)